March 26, 2026 Critical Path Institute Launches ‘One to Millions’ to Reshape the Future of Individualized Medicine at Global Scale C-Path today announced the launch of One to Millions, a global, multi-stakeholder public-private initiative...
March 26, 2026 BioCentury Article: Critical Path Institute Aims to Bring Scale to Individualized Medicines FDA’s plausible mechanism framework aims to accelerate and expand drug development for patients...
March 25, 2026 Closing the Gap: How Better Data Can Transform Kidney Injury Detection In July 2024, I accepted a data manager position within Critical Path Institute’s Data Collaboration Center, unaware...
March 24, 2026 C-Path Taps Veteran Health Technology Leader to Drive Data and AI Strategy as Chief Data and Technology Officer C-Path today announced the appointment of Christopher Lunt as its Chief Data and Technology Officer.
March 23, 2026 Critical Path Institute and Collaborators Honored with Society of Toxicology Science Paper of the Year Award TUCSON, Ariz., March 23, 2026 — Critical Path Institute® (C-Path) announced today that the Society of Toxicology (SOT)...
March 19, 2026 Meeting Patients Where They Are: Validating Remote Digital Tools for Multi-Indication NMD Research The C-Path team is pleased to invite you to an upcoming webinar to discuss the scientific...
March 17, 2026 PBC Ireland Partners with C-Path’s Rare Disease Data Platform, Advancing Research Efforts for Primary Biliary Cholangitis TUCSON, Ariz., March 12, 2026 — In a significant step to enhance research efforts for Primary Biliary Cholangitis...
March 17, 2026 C-Path Biomarker Repository Co-Chair Glenda Roberts Honored with 2026 Derek Forfang Patient Advocate Award C-Path is eager to celebrate the recognition of its Biomarker Data Repository Co-chair Glenda Roberts...
March 12, 2026 The Critical Path Institute Podcast: Connecting the Dots Between T1D and CKD, from the Patient Perspective The newest Critical Path Institute® (C-Path) podcast episode features a candid and inspiring conversation...
March 10, 2026 New Study on Early Parkinson’s Disease Progression Highlights Vital Role of Patient Focused Drug Development and Real-World Impacts TUCSON, Ariz., March 5, 2026 – Critical Path Institute® (C-Path) applauds the publication of a new study in the Journal of...
